Literature DB >> 15176410

[Long-term treatment of phantom- and stump pain with Botulinum toxin type A over 12 months. A first clinical observation].

U Kern1, C Martin, S Scheicher, H Müller.   

Abstract

Recently we were able to describe the successful treatment of phantom pain and stump pain with botulinum toxin A in a first pilot study. This case report over a 1-year period now demonstrates that long-term treatment for this indication is possible. We injected 4 x 25 IU of botulinum toxin A (Botox) into trigger points of the stump muscles of a lower limb amputee who suffered from severe phantom and stump pain. With four injections performed every 3 months, the patient became almost completely pain-free, and his intrathecal morphine therapy could be reduced to 40% of the initial dose. Intrathecal clonidine was eliminated completely, as were the oral analgesics. A surgical treatment suggested for the stump pain was no longer necessary, and we suppose that botulinum toxin can also improve the tolerance of artificial limbs in cases of stump pain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15176410     DOI: 10.1007/s00115-003-1657-4

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  32 in total

1.  [Detection of cortical reorganization after arm amputation and relationship to phantom pain--an fMRI study].

Authors:  T Adler
Journal:  Z Orthop Ihre Grenzgeb       Date:  2001 Mar-Apr

2.  Botulinum toxin for palmar hyperhidrosis.

Authors:  M Naumann; P Flachenecker; E B Bröcker; K V Toyka; K Reiners
Journal:  Lancet       Date:  1997-01-25       Impact factor: 79.321

3.  Dose-dependent, central effects of botulinum neurotoxin type A: a pilot study in the alert behaving cat.

Authors:  B Moreno-López; A M Pastor; R R de la Cruz; J M Delgado-García
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

4.  Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain.

Authors:  Donald R Nixdorf; Giseon Heo; Paul W Major
Journal:  Pain       Date:  2002-10       Impact factor: 6.961

5.  The effect of opioids on phantom limb pain and cortical reorganization.

Authors:  E Huse; W Larbig; H Flor; N Birbaumer
Journal:  Pain       Date:  2001-02-01       Impact factor: 6.961

6.  Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection.

Authors:  R L Rosales; K Arimura; S Takenaga; M Osame
Journal:  Muscle Nerve       Date:  1996-04       Impact factor: 3.217

7.  [Contralateral local anesthesia in the treatment of stump and phantom pain].

Authors:  D Gross
Journal:  MMW Munch Med Wochenschr       Date:  1981-09-04

8.  Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study.

Authors:  A O Ceballos-Baumann; G Sheean; R E Passingham; C D Marsden; D J Brooks
Journal:  Brain       Date:  1997-04       Impact factor: 13.501

9.  Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia.

Authors:  F Gilio; A Currà; C Lorenzano; N Modugno; M Manfredi; A Berardelli
Journal:  Ann Neurol       Date:  2000-07       Impact factor: 10.422

10.  Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.

Authors:  W J Binder; M F Brin; A Blitzer; L D Schoenrock; J M Pogoda
Journal:  Otolaryngol Head Neck Surg       Date:  2000-12       Impact factor: 3.497

View more
  6 in total

Review 1.  Pharmacologic interventions for treating phantom limb pain.

Authors:  Maria Jenelyn M Alviar; Tom Hale; Monalisa Dungca
Journal:  Cochrane Database Syst Rev       Date:  2016-10-14

2.  [Referred pain from amputation stump trigger points into the phantom limb].

Authors:  K-U Kern; C Martin; S Scheicher; H Müller
Journal:  Schmerz       Date:  2006-08       Impact factor: 1.107

Review 3.  Biologic poisons for pain.

Authors:  Lori Reisner
Journal:  Curr Pain Headache Rep       Date:  2004-12

4.  [Effect of botulinum toxin type B on residual limb sweating and pain. Is there a chance for indirect phantom pain reduction by improved prosthesis use?].

Authors:  K-U Kern; M Kohl; U Seifert; T Schlereth
Journal:  Schmerz       Date:  2012-04       Impact factor: 1.107

Review 5.  Botulinum Toxin for Neuropathic Pain: A Review of the Literature.

Authors:  Hyun-Mi Oh; Myung Eun Chung
Journal:  Toxins (Basel)       Date:  2015-08-14       Impact factor: 4.546

Review 6.  Botulinum Toxin for the Treatment of Neuropathic Pain.

Authors:  JungHyun Park; Hue Jung Park
Journal:  Toxins (Basel)       Date:  2017-08-24       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.